Calidi Biotherapeutics Appoints Former Genentech/Roche and Celgene Executive Corsee Sanders, Ph.D., to Board of Directors
Calidi Biotherapeutics appointed Corsee Sanders, Ph.D., a biopharma industry veteran with 23 years of experience at Genentech/Roche, as an independent director to its board. Dr. Sanders previously served as an executive at Juno and advised Celgene and Bristol Myers Squibb following acquisitions, bringing significant clinical development and integration expertise.
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.